Oligonucleotide-conjugates for targeting EpCAM positive tumour cells

This research focuses on targeted drug delivery for cancers using aptamers as novel carriers for drugs. It helps in sparing the normal cells, effecting cancer cells in Epithelial tumours. Both invitro and invivo studies revealed promising results of using aptamers as drug carriers.